OpenAI Targets September IPO with Goldman Sachs and Morgan Stanley Mandated as AI-Linked Convertible Bond Issuance Hits Record Pace
OpenAI, last valued at $852 billion, is preparing to confidentially file for a US initial public offering (IPO — a company's first sale of shares to the public) within weeks, aiming to go public as early as September 2026. Goldman Sachs and Morgan Stanley are working with the company on a draft IPO prospectus for submission to securities regulators. The move comes just days after OpenAI successfully defended an existential legal challenge brought by Elon Musk and follows a $122 billion funding round earlier this year — widely reported as Silicon Valley's largest-ever private fundraising. The planned filing also threatens to overshadow a separate IPO by Musk's SpaceX, which was expected to file around the same period. OpenAI has revised its product roadmap twice in recent months amid intensifying competition from Google and Anthropic, with some analysts projecting Anthropic's revenue growth could surpass OpenAI's within months. The IPO landing in this macro environment is notable: US convertible bond (debt that can be converted into equity) issuance reached approximately $34 billion in the first four months of 2026, more than double the same period a year earlier, with roughly half tied to AI-linked capital expenditure. That surge is itself a signal of how investor appetite for AI-sector equity exposure is driving record debt-market activity — a context that will shape OpenAI's bookbuilding and valuation expectations if it proceeds to a public listing.
Why this matters
An OpenAI IPO at this valuation would be one of the largest technology listings in US capital markets history, generating substantial advisory mandates across equity capital markets (ECM), securities law, and corporate governance. The choice of Goldman and Morgan Stanley as joint bookrunners is consistent with mega-cap tech listings. For UK-nexus relevance, the parallel surge in AI-linked convertible bond issuance — half of all US convertible supply in early 2026 — signals that London's debt capital markets teams will face analogous deal flow as European AI companies seek hybrid financing. The competitive dynamic between OpenAI, Anthropic, and Google also raises questions about IPO timing: a company that has revised its roadmap twice in months will face intense prospectus scrutiny on forward-looking statements and risk disclosures.
On the Ground
On an ECM mandate of this type, a trainee would assist with prospectus drafting and verification — checking that every material statement in the document is supported by a source document — and coordinating comfort letters from auditors confirming financial data. They would also prepare PDMR (person discharging managerial responsibilities) notification letters required once the company is publicly listed.
Interview prep
Soundbite
An $852bn-valued IPO filing compresses the timeline for all AI-sector capital markets work on both sides of the Atlantic.
Question you might get
“What are the key legal risks OpenAI would need to disclose in an IPO prospectus given its recent product roadmap changes and ongoing competition from Anthropic and Google?”
Full answer
OpenAI is preparing to file confidentially for a US IPO within weeks, targeting a September listing at a valuation of $852 billion, with Goldman Sachs and Morgan Stanley as bookrunners. For law firms, this is a landmark ECM instruction: the prospectus, underwriting agreement, and lock-up arrangements alone will occupy large corporate teams for months. The wider significance is that OpenAI's IPO will calibrate how public markets price AI companies with strong revenue growth but contested competitive positions — setting a benchmark for every European AI company considering a listing. The simultaneous record pace of AI-linked convertible bond issuance suggests investor appetite for AI-sector paper is broad enough to absorb supply, which supports the IPO's timing rationale, though the revised product roadmap will require careful handling in risk factor disclosures.
Sources
My notes
saved